Inrig Jula
Travere Therapeutics, Inc. · CHIEF MEDICAL OFFICER
Inrig Jula is listed in filings as CHIEF MEDICAL OFFICER at Travere Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 6, 2026, including sale activity. Recent filings connect the profile to Travere Therapeutics, Inc. (TVTX). The current snapshot covers public activity from Feb 4, 2025 to May 6, 2026. Reported amounts are shown as $13.7K to $900.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $14k311 shares | SellMay 6, 2026 | $43.95 | $55.74 |